| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/18/2000 | CA2348843A1 A capsule based drug delivery system |
| 05/18/2000 | CA2345620A1 Products and methods for brachytherapy |
| 05/17/2000 | EP1000627A1 Aqueous preparation of lactoferrin having improved stability |
| 05/17/2000 | EP1000624A1 Use of DOP as antioxidant, anti-ageing additive and medicament |
| 05/17/2000 | EP1000618A1 Topical capsaicin preparation |
| 05/17/2000 | EP1000617A2 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/17/2000 | EP1000615A2 Preparation of pharmaceutically active particles |
| 05/17/2000 | EP1000082A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/17/2000 | EP1000081A2 A reversible stoichiometric process for conjugating biomolecules |
| 05/17/2000 | EP1000079A1 New formulation |
| 05/17/2000 | EP1000076A1 HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR $i(SHIGELLA DYSENTERIAE) TYPE 1 |
| 05/17/2000 | EP0999855A1 Polymer based pharmaceutical compositions for targeted delivery of biologically active agents |
| 05/17/2000 | EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 05/17/2000 | EP0999853A1 Stabilized antibody formulation |
| 05/17/2000 | EP0999846A1 Phosphatidic acid-based immune modulator composition |
| 05/17/2000 | EP0999843A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 05/17/2000 | EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 05/17/2000 | EP0999838A1 Self-emulsifying formulation for lipophilic compounds |
| 05/17/2000 | EP0999833A1 Taxol emulsion |
| 05/17/2000 | EP0999829A1 Solubilized sertraline compositions |
| 05/17/2000 | EP0999826A1 Self-emulsifying formulation for lipophilic compounds |
| 05/17/2000 | EP0999825A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/17/2000 | EP0831767A4 Alpha hydroxyacid esters for skin aging |
| 05/17/2000 | EP0804246B1 Drug delivery agents incorporating mitomycin |
| 05/17/2000 | EP0804191B1 Use of inhibitors of platelet derived growth receptor for the manufacture of a medicament for the treatment of cancers |
| 05/17/2000 | EP0796238B1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 05/17/2000 | EP0796085B1 Solubilisation aids for hydrophilic macromolecules |
| 05/17/2000 | EP0785920B1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0553272B1 Synthetic lung surfactant |
| 05/17/2000 | CN1253560A Sulfonamides for treatment of endothelin-mediated disorders |
| 05/17/2000 | CN1253503A Stabilized tibolone compositions |
| 05/17/2000 | CN1253499A Drug composition |
| 05/17/2000 | CN1253497A Swallow tablet comprising paracetamol |
| 05/17/2000 | CN1253022A Composition used to enhance permeability of skin medicament |
| 05/17/2000 | CN1253021A Hydroxylated carboxylate or amide used as solubilizing agent |
| 05/17/2000 | CN1052399C Smell covered-up medicine composition |
| 05/17/2000 | CN1052398C Pharmaceutical spheroid formulation |
| 05/17/2000 | CN1052397C Method for preparing pharmaceutical beadlets |
| 05/17/2000 | CA2283516A1 Radioactive stent |
| 05/16/2000 | US6064720 Magnetic support for removable antiscatter grid |
| 05/16/2000 | US6063915 Carrageenan compositions and methods for their production |
| 05/16/2000 | US6063911 Methods and compositions for treatment of cell proliferative disorders |
| 05/16/2000 | US6063909 Preparation of factor IX |
| 05/16/2000 | US6063821 Antiinflammatory agents and extrusion for administering and antipyretics |
| 05/16/2000 | US6063776 Anticholesterol agents |
| 05/16/2000 | US6063761 Hepatoselective pharmaceutical actives |
| 05/16/2000 | US6063759 Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting |
| 05/16/2000 | US6063758 Substance P-Saporin (SP-SAP) conjugates and methods of use thereof |
| 05/16/2000 | US6063625 Regulated transcription of targeted genes and other biological events |
| 05/16/2000 | US6063405 Sustained release delivery system |
| 05/16/2000 | US6063404 Bioadhesive tablet |
| 05/16/2000 | US6063402 Purified galactomannan as an improved pharmaceutical excipient |
| 05/16/2000 | US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 05/16/2000 | US6063396 Methods and compositions for the modulation of cell proliferation and wound healing |
| 05/16/2000 | US6063394 Injection formulations of avermectins and milbemycins based on castor oil |
| 05/16/2000 | US6063388 Mixture of parahydroxybenzoate, n-(3-chloroallyl)hexammonium chloride and sodium benzoate |
| 05/16/2000 | US6063370 Drug, polymer complex |
| 05/16/2000 | US6063313 Blending and extrusion of drugs, spheronizing and drying |
| 05/16/2000 | US6063116 Modulation of cell proliferation and wound healing |
| 05/16/2000 | US6063061 Fragmented polymeric compositions and methods for their use |
| 05/16/2000 | CA2173403C External therapeutic composition for dermatitis |
| 05/16/2000 | CA2098893C Antioxidant composition of natural products and method of production thereof |
| 05/16/2000 | CA2090033C Conjugated moieties for chelating paramagnetic metals |
| 05/16/2000 | CA2044548C Coating process by a ph-sensitive polymer of active ingredients |
| 05/16/2000 | CA2006778C Nifedipine pharmaceutical preparation |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026185A2 Omeprazole solution and method of using same |
| 05/11/2000 | WO2000025908A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 05/11/2000 | WO2000025841A1 Implant with cavities containing therapeutic agents |
| 05/11/2000 | WO2000025831A1 A new composition and method for increasing production yield of agriculturally useful species |
| 05/11/2000 | WO2000025826A1 Lactone bearing absorbable polymers |
| 05/11/2000 | WO2000025825A1 Dds compounds and method for assaying the same |
| 05/11/2000 | WO2000025824A2 Stable preparations with hyperforin |
| 05/11/2000 | WO2000025823A1 Muco-adhesive polymers, use thereof and method for producing the same |
| 05/11/2000 | WO2000025822A1 Transdermal delivery of medications using a combination of penetration enhancers |
| 05/11/2000 | WO2000025812A2 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | WO2000025785A1 Plastics container containing stabilised drug formulations |
| 05/11/2000 | WO2000025775A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 05/11/2000 | WO2000025772A1 Compositions of and process for producing isotretinoin having low particle size |
| 05/11/2000 | WO2000025761A1 Capsules with porous mineral cortex |
| 05/11/2000 | WO2000025760A1 Process for producing hard capsule |
| 05/11/2000 | WO2000025758A1 Oral administration of adenosine analogs |
| 05/11/2000 | WO2000025753A2 Controlled delivery of active agents |
| 05/11/2000 | WO2000025752A1 Multiparticulate modified release composition |
| 05/11/2000 | WO2000025744A1 Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| 05/11/2000 | WO2000025742A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 05/11/2000 | WO2000025723A2 Methods and compositions for the prevention of tolerance to medications |
| 05/11/2000 | WO2000025606A1 Solid delivery systems for aroma ingredients |
| 05/11/2000 | WO2000007572A3 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 05/11/2000 | WO2000007543A3 Conjugates targeted to the interleukin-2 receptors |
| 05/11/2000 | WO2000006124A3 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 05/11/2000 | DE19910188A1 Implant, especially a stent, comprises a support at least partly covered with a layer of metal oxide and/or ceramic material to inhibit excessive cell growth |
| 05/11/2000 | DE19903570A1 Stabile Zubereitungen mit Hyperforin Stable preparations with hyperforin |
| 05/11/2000 | DE19855421A1 Implant, especially a stent, having surface cavities containing a radioactive material to inhibit excessive cell growth |
| 05/11/2000 | DE19851777A1 Verwendung von Estern oder Amiden hydroxylierter Carbonsäuren als Solubilisatoren The use of esters or amides of hydroxylated carboxylic acids as solubilizers |
| 05/11/2000 | DE19851282A1 Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten Composition of a pharmaceutically active substance, applied in a specific delivery system for the prevention and treatment of infectious diseases |
| 05/11/2000 | CA2653839A1 Multiparticulate modified release composition |